Spexis to host business update conference call on October 9, 2023 – Biotech Investments
Spexis AG / Key word(s): Statement Spexis to host business update conference call on October 9, 2023 06.10.2023 / 07:30 CET/CEST Spexis to host
Spexis AG / Key word(s): Statement Spexis to host business update conference call on October 9, 2023 06.10.2023 / 07:30 CET/CEST Spexis to host
The FDA handed down a complete response letter to Aldeyra Therapeutics for its dry eye disease drug reproxalap, following months of speculation about whether the
Earlier this month, the U.K. government issued a proposal to gather information and opinions about payments that drug and device makers give to the medical